FDA Clearance Tracker · P150031-S065
Vercise Genus DBS System, Vercise Gevia DBS System, Vercise PC DBS System
Last checked: Nov 20, 2026Latest source record: Nov 13, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Nov 13, 2024
Approved
Time to decision
411 days
Received Sep 29, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150031-S065
- Device name
- Vercise Genus DBS System, Vercise Gevia DBS System, Vercise PC DBS System
- Applicant
- Boston Scientific Corp
- Applicant location
- Valencia, CA
- Received
- Sep 29, 2023
- Decided
- Nov 13, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P150031
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
which requested approval for the following: Vercise Cartesia X Directional Lead Kits (Models DB-2203-30B and DB-2203-45B), Vercise Cartesia HX 16-contact Directional Lead Kits (Models DB-2204-30B and DB-2204-45B), 16-contact Lead Extension Kits (Models DB-3216-55 and DB-3216-95), 2x8 Lead Extension Kits (Models DB-3128 and DB-3128-95), and Vercise Physicians Spare Kit (Model DB-2501).
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.